249 filings
Page 3 of 13
8-K
0of7p8 c8swy
17 May 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7:30am
8-K
2chrn4d643sufmf
13 May 21
Molecular Templates, Inc. Reports First Quarter 2021 Financial Results
4:30pm
8-K
0zgow326l8
5 Apr 21
Termination of a Material Definitive Agreement
7:38am
8-K
fh7iumij
19 Mar 21
Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results
12:00am
8-K
qj7kk3r
22 Feb 21
Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock
4:36pm
8-K
q7wtgbnbuhzatzl
17 Feb 21
Other Events
4:14pm
8-K
sszn8db
11 Feb 21
Molecular Templates to receive $70 million upfront payment with potential for additional milestone and royalty payments on future sales
7:36am
8-K
in339
7 Jan 21
Regulation FD Disclosure
8:00am
8-K
tusq7zysqz
5 Nov 20
Molecular Templates, Inc. Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
4:32pm
8-K
ug1c3ozdyfewy01 e2x
6 Aug 20
Molecular Templates, Inc. Reports Second Quarter 2020 Financial Results
4:57pm
8-K
i0aovk
20 Jul 20
Other Events
4:30pm
8-K
x9uy mgsuoxy106rz
28 May 20
Submission of Matters to a Vote of Security Holders
5:10pm
8-K
k3zd5 bba
22 May 20
Molecular Templates, Inc. Announces $45 Million Debt Financing from K2 Healthventures
8:20am
8-K
yqfphg33z ztds
11 May 20
Molecular Templates, Inc. Reports First Quarter 2020 Financial Results
4:30pm
8-K
e03c1jc0g29smo
12 Mar 20
Molecular Templates, Inc. Reports Fourth Quarter 2019 Financial Results
4:30pm
8-K
fp3hbno
19 Dec 19
Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors
5:23pm
8-K
adtvsyc5
25 Nov 19
Molecular Templates, Inc. Announces Proposed Public Equity Offering
9:01am
8-K
hf9vbovfykom
18 Nov 19
Entry into a Material Definitive Agreement
7:09am
8-K
6yin gwpfohqovq
12 Nov 19
Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results
5:00pm
8-K
z98svf2oj4d
24 Sep 19
Regulation FD Disclosure
8:01am